(Q42721039)
Statements
1 reference
Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors (English)
1 reference
1 reference
J Baselga
1 reference
B Markman
1 reference
I Krop
1 reference
G I Shapiro
1 reference
L Siu
1 reference
L C Chen
1 reference
M Mita
1 reference
M Melendez Cuero
1 reference
S Stutvoet
1 reference
D Birle
1 reference
O Anak
1 reference
W Hackl
1 reference
22 February 2012
1 reference
1 reference
Identifiers
1 reference